You are here
IMPC members give two presentations at the RE(ACT) Rare Disease Meeting in Basel, Switzerland
IMPC was featured in two talks at the RE(ACT) "2nd International Congress on Research of Rare and Orphan Disease" held from March 5th to March 8th at the Gehry Building on the Novartis Campus in Basel, Switzerland. The goals of this congress are to promote research on rare and orphan disease among the general public, industry and policy makers. Dr. Colin McKerlie, Senior Associate Scientist of The Hospital for Sick Children and Professor at the University of Toronto, gave an overview of IMPC activities and how it was generating many relevant mouse modesl of human disease that are available for the rare disease research community. A second talk by Terry Meehan of EMBL-EBI focused on the informatics infrastructure for IMPC and how phenotypes for mouse knockout strains could be used in the ranking of disease causing variants in human disease patients. Both talks were well received with much interest in how researchers could find mutant mouse strains for their own studies.